St. Jude Medical, Inc. STJ, a global medical device company, today
announced European CE Mark approval of its AMPLATZER^™ Amulet^™ Left Atrial
Appendage Occluder. The Amulet device is used to close the left atrial
appendage (LAA) in patients diagnosed with non-valvular atrial fibrillation
(AF). According to research, AF leads to an increased risk for stroke. Sealing
off the LAA helps prevent the risk of blood clot formation and release,
potentially reducing the risk of stroke. The next-generation percutaneous
transcatheter device leverages the design and clinical success of the original
AMPLATZER^™ Cardiac Plug with additional features allowing treatment of a
wider range of appendage anatomies. St. Jude Medical will be showcasing the
new AMPLATZER Amulet device during the eighteenth annual Boston AF Symposium
at booth 319.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in